# Micro Glucagon During Exercise in Type 1 Diabetes

> **NCT04192019** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Insel Gruppe AG, University Hospital Bern**

## Conditions studied

- Type 1 Diabetes
- Hypoglycemia

## Interventions

- **DRUG:** Micro-glucagon
- **DRUG:** Mini-glucagon

## Key facts

- **NCT ID:** NCT04192019
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-04
- **Primary completion:** 2024-04
- **Final completion:** 2024-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Prioritization of other projects
- **Last updated:** 2023-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04192019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04192019, "Micro Glucagon During Exercise in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04192019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*